Clinical Trials Directory

Trials / Completed

CompletedNCT00179868

C-Reactive Protein as a Predictor of Stem Cell Transplant Complications

C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
Sex
All
Age
6 Months – 20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.

Conditions

Interventions

TypeNameDescription
BEHAVIORALC-Reactive Protein levelsEach patient enrolled in the study will have a serum quantitative c-reactive protein (crp) level drawn on the day of transplant, day 7 of transplant, and twice weekly after that until recovery of neutrophil count (approximately 20-25 days). Patients will be followed for 100 days post-transplant for the development of the following complications: 1. Sepsis- defined as fever, positive blood culture, need for fluid resuscitation and/or pressor support. 2. Acute GVHD \> grade II defined according to the Seattle criteria 3. VOD- defined according to the modified Seattle criteria

Timeline

Start date
2003-01-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2005-09-16
Last updated
2025-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00179868. Inclusion in this directory is not an endorsement.